Argent BioPharma (RGT), formerly MGC Pharmaceuticals, has sold the global commercialisation rights of its leading epilepsy drug, CannEpil, in order to clear a sizable chunk of its debt.
Newly rebranded California-based cannabis operator Eaze raised $10 million to acquire select assets of Eaze Technologies, its predecessor company, to fund the reopening of 70 Eaze and Green Dragon locations across California, Colorado, Florida and Michigan.
California’s Department of Cannabis Control (DCC) has announced it has doubled funding for the Phase II round of its Local Jurisdiction Retail Access Grant programme.
